These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 26689954)

  • 1. Effect of Antenatal Treatment on the Severity of Congenital Toxoplasmosis.
    Wallon M; Peyron F
    Clin Infect Dis; 2016 Mar; 62(6):811-2. PubMed ID: 26689954
    [No Abstract]   [Full Text] [Related]  

  • 2. [Toxoplasmosis. Recommendations for treatment of primary toxoplasma infection in pregnancy and congenital toxoplasmosis].
    Aspöck H; Husslein P; Janisch H; Möse JR; Pollak A; Vander-Möse A; Winter R
    Gynakol Geburtshilfliche Rundsch; 1994; 34(1):50-1. PubMed ID: 8019174
    [No Abstract]   [Full Text] [Related]  

  • 3. Possibilities for Immunomodulation in Congenital Toxoplasmosis.
    Gómez Marín JE
    J Infect Dis; 2016 Aug; 214(4):656. PubMed ID: 27357341
    [No Abstract]   [Full Text] [Related]  

  • 4. [Value of prevention of congenital toxoplasmosis].
    Douche C; Benabdesselam A; Mokhtari F; Le Mer Y
    J Fr Ophtalmol; 1996; 19(5):330-4. PubMed ID: 8762899
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Congenital toxoplasmosis following infection occurring late in pregnancy].
    Ben Abdallah R; Siala E; Maatoug R; Souissi O; Aoun K; Bouratbine A
    Arch Pediatr; 2011 Jul; 18(7):758-60. PubMed ID: 21632221
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Congenital toxoplasmosis and cerebral involvement inspite of prenatal treatment].
    Gire C; Nicaise C; Minodier P; Palix C; Boubli L; Garnier JM
    Presse Med; 1999 Apr; 28(13):686-8. PubMed ID: 10228476
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neuropsychiatric manifestations of latent toxoplasmosis on mothers and their offspring.
    Abdoli A; Dalimi A; Arbabi M; Ghaffarifar F
    J Matern Fetal Neonatal Med; 2014 Sep; 27(13):1368-74. PubMed ID: 24156764
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Diagnosis and therapy of congenital toxoplasmosis].
    Friese K; Weigel M; Melchert F
    Dtsch Med Wochenschr; 1993 Dec; 118(49):1814-6. PubMed ID: 8253045
    [No Abstract]   [Full Text] [Related]  

  • 9. [Gestational and congenital toxoplasmosis: a practical approach to disease notification].
    Capobiango JD; Breganó RM; Mori FM; Navarro IT; Campos JS; Tatakihara LT; Talizin TB; Santos MD; Pereira TR; Narciso SG; Reiche EM
    Epidemiol Serv Saude; 2016; 25(1):187-194. PubMed ID: 27861692
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Risk factors for Toxoplasma gondii infection in mothers of infants with congenital toxoplasmosis: implications for prenatal management and screening.
    Levine EM
    Am J Obstet Gynecol; 2006 Feb; 194(2):589; author reply 590. PubMed ID: 16458668
    [No Abstract]   [Full Text] [Related]  

  • 11. [Real-time quantitative PCR for toxoplasmosis diagnosis].
    Ordinaire I; Simon A; Fréalle E; Soula F; Valat AS; Rouland V; Subtil D; Dei-Cas E; Camus D; Delhaes L
    Ann Biol Clin (Paris); 2005; 63(1):67-73. PubMed ID: 15689314
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Good's syndrome and congenital toxoplasmosis due to maternal reactivation during pregnancy].
    Tahiri J; Fouyssac F; Morel O; Maatouk A
    Rev Med Interne; 2017 May; 38(5):337-339. PubMed ID: 28347510
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Congenital toxoplasmosis: transmission to the fetus of a pre-pregnancy maternal infection].
    Pons JC; Sigrand C; Grangeot-Keros L; Frydman R; Thulliez P
    Presse Med; 1995 Jan; 24(3):179-82. PubMed ID: 7899358
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Evaluation of prevention strategies for congenital toxoplasmosis: a critical review of medico-economic studies].
    Binquet C; Wallon M; Quantin C; Gadreau M; Peyron F
    Rev Epidemiol Sante Publique; 2002 Oct; 50(5):475-87. PubMed ID: 12471340
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The program for antenatal screening of toxoplasmosis in Finland: a prospective cohort study.
    Koskiniemi M; Lappalainen M; Koskela P; Hedman K; Ammälä P; Hiilesmaa V; Teramo K
    Scand J Infect Dis Suppl; 1992; 84():70-4. PubMed ID: 1290079
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Systematic serologic screening for toxoplasmosis in pregnancy.
    Thorp JM
    Obstet Gynecol; 1993 Jul; 82(1):162-3. PubMed ID: 8369057
    [No Abstract]   [Full Text] [Related]  

  • 17. [Congenital toxoplasmosis due to maternal reinfection during pregnancy].
    Valdès V; Legagneur H; Watrin V; Paris L; Hascoët JM
    Arch Pediatr; 2011 Jul; 18(7):761-3. PubMed ID: 21600743
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Incidence of toxoplasmosis during pregnancy and risk of fetal infection].
    Ben Ayed Nouira N; Hafsia S; Khaled S; Zhioua F; Ferchiou M; Jedoui A; Meriah S; Ben Rachid MS
    Tunis Med; 1994; 72(8-9):487-91. PubMed ID: 7716814
    [No Abstract]   [Full Text] [Related]  

  • 19. [Toxoplasmosis screening: tu felix Austria--response].
    Hayde M; Pollak A; Aspöck H
    Wien Klin Wochenschr; 1998 Jan; 110(2):63-5. PubMed ID: 9531682
    [No Abstract]   [Full Text] [Related]  

  • 20. Factors affecting the adherence to an antenatal screening programme: an experience with toxoplasmosis screening in France.
    Cornu C; Bissery A; Malbos C; Garwig R; Cocherel C; Ecochard R; Peyron F; Wallon M
    Euro Surveill; 2009 Mar; 14(9):21-5. PubMed ID: 19317970
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.